FI954990A0 - Transdermalt preparat innehållande en aktiv substans - Google Patents

Transdermalt preparat innehållande en aktiv substans

Info

Publication number
FI954990A0
FI954990A0 FI954990A FI954990A FI954990A0 FI 954990 A0 FI954990 A0 FI 954990A0 FI 954990 A FI954990 A FI 954990A FI 954990 A FI954990 A FI 954990A FI 954990 A0 FI954990 A0 FI 954990A0
Authority
FI
Finland
Prior art keywords
pct
active substance
preparation containing
transdermal preparation
sec
Prior art date
Application number
FI954990A
Other languages
English (en)
Finnish (fi)
Other versions
FI114444B (sv
FI954990A (sv
Inventor
Wilfried Fischer
Thomas Struengmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of FI954990A0 publication Critical patent/FI954990A0/sv
Publication of FI954990A publication Critical patent/FI954990A/sv
Application granted granted Critical
Publication of FI114444B publication Critical patent/FI114444B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI954990A 1993-04-23 1995-10-19 Förfarande för framställning av ett transdermalt preparat innehållande ett verksamt ämne FI114444B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4313402 1993-04-23
DE4313402A DE4313402A1 (de) 1993-04-23 1993-04-23 Transdermale Wirkstoffzubereitung
PCT/EP1994/001259 WO1994025069A1 (de) 1993-04-23 1994-04-22 Transdermale wirkstoffzubereitung
EP9401259 1994-04-22

Publications (3)

Publication Number Publication Date
FI954990A0 true FI954990A0 (sv) 1995-10-19
FI954990A FI954990A (sv) 1995-11-23
FI114444B FI114444B (sv) 2004-10-29

Family

ID=6486248

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954990A FI114444B (sv) 1993-04-23 1995-10-19 Förfarande för framställning av ett transdermalt preparat innehållande ett verksamt ämne

Country Status (13)

Country Link
US (1) US5738869A (sv)
EP (1) EP0695193B1 (sv)
JP (1) JP4334613B2 (sv)
AT (1) ATE176593T1 (sv)
AU (1) AU6721094A (sv)
DE (2) DE4313402A1 (sv)
DK (1) DK0695193T3 (sv)
ES (1) ES2130420T3 (sv)
FI (1) FI114444B (sv)
GR (1) GR3029963T3 (sv)
NO (1) NO311919B1 (sv)
WO (1) WO1994025069A1 (sv)
ZA (1) ZA942848B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6623752B1 (en) * 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19641259A1 (de) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Diclofenac
CN1072482C (zh) * 1996-11-08 2001-10-10 山东医科大学 低分子肝素脂质体喷胶剂及制备工艺
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19945522A1 (de) * 1999-09-23 2001-04-05 Hexal Ag Pharmazeutisches, wirkstoffhaltiges Gel
BR0001144B1 (pt) * 2000-02-21 2013-10-22 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10137082A1 (de) * 2001-07-28 2003-02-13 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
US6936273B2 (en) * 2002-12-20 2005-08-30 Idexx Laboratories, Inc. Liposomal analgesic formulation and use
EP1572152B1 (en) * 2002-12-20 2008-02-13 Idexx Laboratories, Inc. Liposomal analgesic formulation comprising diclofenac and its use for treatment of horses
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1819297B1 (en) 2004-09-28 2015-01-14 Atrium Medical Corporation Uv cured gel and method of making
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006103091A1 (en) * 2005-03-31 2006-10-05 Unilever Plc Enhanced delivery of skin benefit agents
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
NZ577020A (en) 2006-10-17 2012-05-25 Nuvo Res Inc Diclofenac gel containing dimethyl sulfoxide (dmso)
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
WO2009101412A1 (en) * 2008-02-13 2009-08-20 Cipla Limited Topical pharmaceutical composition
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
RU2532027C2 (ru) * 2009-07-24 2014-10-27 Мика Фарма Гезельшафт Фюр Ди Энтвиклюнг Унд Фермарктунг Фармацойтишер Продукте Мбх Жидкие композиции, способные к пенообразованию и включающие активные средства, и способы их получения и разработки
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US20130309215A1 (en) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Fur Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmaceutical composition
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
JP6449554B2 (ja) * 2014-03-30 2019-01-09 小林製薬株式会社 外用医薬組成物
EA201791437A1 (ru) 2014-12-31 2017-12-29 Лантеус Медикал Имэджинг, Инк. Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы
JP6542006B2 (ja) * 2015-03-31 2019-07-10 小林製薬株式会社 外用医薬組成物
CN109641068B (zh) 2016-05-04 2022-09-30 蓝瑟斯医学影像公司 用于制备超声波造影剂的方法及装置
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
CA3038702A1 (en) * 2016-10-18 2018-04-26 Lts Lohmann Therapie-Systeme Ag Two-layer topical therapeutic system

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
EP0151989B1 (de) * 1984-01-28 1991-04-10 Roshdy Dr. Ismail Mittel zur Behandlung von Herzerkrankungen
DE3402928A1 (de) * 1984-01-28 1985-08-08 Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail Mittel zur behandlung von herzerkrankungen
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
CA1257200A (en) * 1984-03-07 1989-07-11 Roshdy Ismail Agents for the treatment and protection of the skin
DE3507791A1 (de) * 1984-03-07 1985-09-26 Roshdy Ismail Mittel zum schutz der haut
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3506881A1 (de) * 1985-02-27 1986-08-28 RODISMA pharmazeutische Produkte GmbH, 5000 Köln Vitamin e spray
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4745105A (en) * 1986-08-20 1988-05-17 Griffin Charles C Low molecular weight heparin derivatives with improved permeability
US4745107A (en) * 1986-08-20 1988-05-17 Foley Kevin M Heparin derivatives with improved permeability
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IT1229489B (it) * 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
DE3904674A1 (de) * 1989-02-16 1990-08-23 Cassella Ag Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
AU664178B2 (en) * 1991-03-19 1995-11-09 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0695193A1 (de) 1996-02-07
DE4313402A1 (de) 1994-10-27
ATE176593T1 (de) 1999-02-15
FI114444B (sv) 2004-10-29
EP0695193B1 (de) 1999-02-10
ZA942848B (en) 1995-10-25
US5738869A (en) 1998-04-14
ES2130420T3 (es) 1999-07-01
GR3029963T3 (en) 1999-07-30
JPH08509715A (ja) 1996-10-15
NO954215L (no) 1995-12-14
AU6721094A (en) 1994-11-21
FI954990A (sv) 1995-11-23
NO954215D0 (no) 1995-10-20
NO311919B1 (no) 2002-02-18
DK0695193T3 (da) 1999-09-20
DE59407810D1 (de) 1999-03-25
WO1994025069A1 (de) 1994-11-10
JP4334613B2 (ja) 2009-09-30

Similar Documents

Publication Publication Date Title
FI954990A (sv) Transdermalt preparat innehållande en aktiv substans
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ES2097546T3 (es) Preparaciones cosmeticas desodorantes que contienen esteres di- o trigliceridos.
ATE423547T1 (de) N-acyl-phosphatidylethanolamin-vermittelte wirkstoffdarreichung in liposomenform
PT698393E (pt) Agente de solubilizacao e preparacao para uso externo contendo o mesmo
DK0948965T3 (da) Stabile medicinske præparater indeholdende 4,5-epoxymorphinanderivater
MY112915A (en) Multiple unit tableted dosage form 1
AU2001236744A1 (en) Delivery system for topical skin care agents
WO1992002212A3 (en) Use of interfacially-polymerized membranes in delivery devices
ES2092876T3 (es) Composicion despigmentante para el tratamiento simultaneo de las capas superficiales y profundas de la piel.
FI956014A0 (sv) Användning av nona- och dekapeptider för framställning av läkemedel för behandling av AIDS
MXPA03011825A (es) Combinacion de ingrediente activo para tratar una dependencia de sustancias aditivas o narcoticas utilizando medicamentos.
FI962220A0 (sv) Transdermalt terapeutiskt system
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
CY1105463T1 (el) Ελεγχομενη χορηγηση αντικαταθλιπτικων
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
GR3030954T3 (en) Children-proof package for active substance-containing plaster
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2122005T3 (es) Medicamento que contiene (-)-metrifonato.
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ATE211383T1 (de) Topische aciclovir-zubereitung
AR034767A1 (es) Combinacion de principios activos para la terapia medicinal de la dependencia a la nicotina.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114444

Country of ref document: FI

MM Patent lapsed